Cargando…
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
BACKGROUND AND OBJECTIVE: In the absence of characterization on pharmacokinetics and reference concentrations for hydroxychloroquine in COVID-19 patients, the dose and treatment duration for hydrochloroquine are currently empirical, mainly based on in vitro data, and may vary across national guideli...
Autores principales: | Thémans, Pauline, Belkhir, Leila, Dauby, Nicolas, Yombi, Jean-Cyr, De Greef, Julien, Delongie, Kevin-Alexandre, Vandeputte, Martin, Nasreddine, Rakan, Wittebole, Xavier, Wuillaume, Francoise, Lescrainier, Cécile, Verlinden, Veerle, Kiridis, Sophie, Dogné, Jean-Michel, Hamdani, Jamila, Wallemacq, Pierre, Musuamba, Flora T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511144/ https://www.ncbi.nlm.nih.gov/pubmed/32968954 http://dx.doi.org/10.1007/s13318-020-00648-y |
Ejemplares similares
-
A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium
por: Wallemacq, Silvio, et al.
Publicado: (2022) -
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center
por: Pothen, Lucie, et al.
Publicado: (2020) -
Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection
por: Bizimungu, Christelle, et al.
Publicado: (2023) -
Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia
por: Thémans, Pauline, et al.
Publicado: (2019) -
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)